Women's Health
What Causes Low Ferritin in Women?
Ferritin can fall silently for months before hemoglobin ever budges — leaving women with textbook iron-deficiency symptoms and a 'normal' blood panel. Up to 30% of premenopausal women have ferritin below 30 ng/mL, the level at which fatigue, hair loss, and cognitive slowing reliably emerge in clinical trials.

What Causes Low Ferritin in Women?
Low ferritin in women is most often caused by menstrual blood loss, inadequate dietary iron, or poor absorption — and frequently all three at once. The main caveat is that ferritin is also an acute-phase reactant, so inflammation can falsely normalize a low result. The exception is women with heavy periods or endometriosis, where depletion can be severe enough to cause symptoms even when ferritin sits in the so-called "normal" reference range.
---
Understanding Ferritin: What the Number Actually Means
Ferritin is the primary iron storage protein in the body. Each ferritin molecule can hold up to 4,500 iron atoms, making it the central reservoir your bone marrow, muscles, thyroid, and immune system all draw from. When dietary intake or absorption can't keep pace with losses, ferritin falls first — often weeks or months before hemoglobin drops, which is why standard anemia panels miss the problem entirely.
Reference ranges vary by lab, but most set the lower boundary somewhere between 10–20 ng/mL. That floor is far too low for functional health. The clinical reality, supported by multiple trials, is that symptoms of iron insufficiency — fatigue, hair loss, impaired exercise tolerance, and cognitive slowing — begin well above the anemia threshold.
| Ferritin Level (ng/mL) | Clinical Interpretation |
|---|---|
| < 15 | Iron-deficient; anemia likely to develop |
| 15–30 | Suboptimal; symptomatic in many women |
| 30–70 | Low-normal; still associated with fatigue in active women |
| 70–150 | Optimal functional range for most adults |
| > 200 | Elevated; may reflect inflammation or hemochromatosis |
A 2003 randomized controlled trial by Verdon et al. found that women with unexplained fatigue and ferritin ≤ 50 ng/mL who received iron supplementation reported significantly greater improvement in fatigue scores than placebo — even though none had hemoglobin below 12 g/dL (Verdon et al., BMJ 2003; PMID: 12509636). This study alone argues for expanding the clinical threshold well beyond what most labs flag as abnormal.
It is also worth noting that ferritin can appear falsely elevated when CRP is high, because both are synthesized in the liver as acute-phase proteins. A woman with early-stage inflammatory bowel disease, for instance, may have a ferritin of 45 ng/mL that masks true stores closer to 20 ng/mL. Running a concurrent CRP or serum transferrin saturation gives a more honest picture of iron status.
---
Symptoms of Low Ferritin
The symptom picture of low ferritin is frustratingly non-specific, which is part of why it takes women multiple clinical visits before it is correctly identified. Symptoms track closely with tissue-level iron depletion rather than with hemoglobin, meaning a woman can be profoundly iron-depleted and still receive a clean CBC.
Common symptoms include:
- Persistent fatigue disproportionate to sleep quality or sleep duration
- Hair shedding, particularly diffuse telogen effluvium (see why low ferritin drives hair loss for the full biochemistry)
- Restless legs syndrome — iron is a cofactor in dopamine synthesis in the basal ganglia
- Cold intolerance, since iron-dependent enzymes support thermogenesis
- Exercise intolerance and reduced VO₂ max even without anemia
- Brain fog, poor working memory, and slowed processing speed
- Brittle nails and koilonychia (spoon-shaped nails) in more severe cases
- Frequent infections, as iron-dependent enzymes fuel neutrophil respiratory burst
A double-blind RCT by Bruner et al. in 1996 showed that adolescent girls with ferritin below 16 ng/mL but non-anemic hemoglobin performed measurably worse on attention and memory tests, and that iron supplementation over 8 weeks produced significant improvements in verbal learning and memory compared to placebo (Bruner et al., Lancet 1996; PMID: 8598707). The cognitive dimension of iron insufficiency is chronically underappreciated in clinical practice.
Hair loss warrants particular attention. A cross-sectional study by Kantor et al. found that women with telogen effluvium had significantly lower mean ferritin levels (23 ng/mL) compared to healthy controls (43 ng/mL), and that a ferritin threshold of 40 ng/mL was suggested as the minimum for hair follicle cycle support (Kantor et al., Journal of Investigative Dermatology 2003; PMID: 12755958). Dermatologists are increasingly adopting 70 ng/mL as the functional target for women actively treating hair loss.
---
Root Causes of Low Ferritin in Women
Understanding the mechanism behind a low ferritin result is what separates a useful intervention from one that stalls. There are six primary etiologies, and more than one often operates simultaneously.
1. Menstrual Blood Loss
Each milliliter of blood contains approximately 0.5 mg of iron. A woman with heavy menstrual bleeding (defined as > 80 mL per cycle) can lose 40+ mg of iron per period — a figure that far outpaces the 18 mg RDA, let alone average dietary intake. Population data suggest that 10–20% of premenopausal women meet the clinical definition of heavy menstrual bleeding, making this the single largest structural cause of low ferritin in this demographic.
Endometriosis compounds the problem. Beyond blood loss at menstruation, endometriotic lesions create localized iron dysregulation through heme accumulation and oxidative stress. Women with confirmed endometriosis are significantly more likely to present with ferritin below 30 ng/mL even after controlling for total blood loss (Donnez & Dolmans, Endocrine Reviews 2022; doi.org/10.1210/endrev/bnac015).
2. Inadequate Dietary Iron Intake
Heme iron (from animal sources) absorbs at 15–35%, while non-heme iron (from plants) absorbs at only 2–20% depending on the meal context. Women following plant-based or vegetarian diets carry an approximately 1.8× higher iron requirement according to the Institute of Medicine, because non-heme iron competes with phytates, calcium, and polyphenols for absorption at the duodenal enterocyte.
This is particularly relevant among women who have reduced red meat consumption — a common dietary shift — without adequately compensating through iron-rich plant sources paired with vitamin C. A dietary analysis needs to look beyond total iron content and evaluate the ratio of heme to non-heme sources, plus ascorbic acid intake at iron-containing meals.
3. Malabsorption
Iron is absorbed almost entirely in the proximal duodenum via the divalent metal transporter DMT-1. Any pathology disrupting duodenal mucosa — celiac disease, Crohn's disease affecting the small bowel, H. pylori infection, or gastric bypass surgery — dramatically reduces absorptive capacity. Celiac disease is the most commonly missed cause in women presenting with unexplained low ferritin; iron-deficiency anemia is the presenting complaint in 5–11% of newly diagnosed celiac patients (Hershko & Camaschella, Blood 2014; PMID: 24553186).
H. pylori infection in the stomach impairs iron absorption even in the absence of an ulcer by raising gastric pH and competing directly for dietary iron. Testing for H. pylori is an underused step in the workup of refractory iron deficiency.
4. Increased Physiological Demand
Pregnancy increases iron requirements to approximately 27 mg/day, a nearly 50% jump from baseline. Competitive endurance training raises demand further still, as foot-strike hemolysis, increased gastrointestinal blood loss, and elevated erythropoiesis (driven by training adaptation) all pull from the same storage pool. Female athletes are a recognized high-risk group, with prevalence of low ferritin estimated at 15–35% depending on sport and training volume.
5. Chronic Inflammation and Hepcidin Elevation
Hepcidin, the master iron regulatory hormone produced by the liver, blocks ferroportin — the main iron exporter at the gut lining and macrophage surface. When hepcidin is chronically elevated due to low-grade inflammation (from obesity, autoimmune disease, gut dysbiosis, or chronic infection), iron gets trapped in storage cells and duodenal absorption is actively suppressed. The result is functional iron deficiency: iron is present in the body but unavailable to erythroid precursors or storage as ferritin.
This is the scenario where CRP context becomes critical. A ferritin of 60 ng/mL alongside a CRP of 12 mg/L tells a very different clinical story from a ferritin of 60 ng/mL with a CRP of 0.4 mg/L. Stress, whether metabolic or psychological, is a meaningful upstream driver of this pathway — because chronic cortisol elevation upregulates inflammatory cytokines IL-6 and TNF-α, which in turn stimulate hepcidin synthesis. Women dealing with prolonged high-stress periods often show subtle but measurable shifts in iron metabolism even without overt inflammatory disease.
6. Thyroid Dysfunction
Hypothyroidism, which disproportionately affects women, reduces gastric acid production and slows intestinal transit — both of which reduce iron absorption. It also impairs the production of transferrin, the protein that carries iron in circulation. Thyroid hormones additionally regulate erythropoietin synthesis in the kidney, so even borderline hypothyroidism can quietly blunt red blood cell production and increase iron demand. Women with low vitamin D frequently co-present with thyroid dysfunction and low ferritin, pointing to a shared upstream driver of impaired micronutrient status.
---
Lab Markers Worth Ordering Alongside Ferritin
Ferritin alone is insufficient for a complete iron assessment. An effective panel includes:
| Marker | What It Adds |
|---|---|
| Serum ferritin | Iron stores (but confounded by inflammation) |
| Serum iron | Circulating iron available for use |
| TIBC (Total Iron Binding Capacity) | High in iron deficiency; low in inflammation |
| Transferrin saturation (%) | < 20% suggests functional deficiency |
| CRP or hs-CRP | Flags if ferritin is falsely elevated |
| Hemoglobin + hematocrit | Detects frank anemia |
| Reticulocyte hemoglobin content | Earliest marker of iron-restricted erythropoiesis |
| Serum B12 + folate | Co-deficiencies that mimic or mask iron deficiency |
| TSH + Free T4 | Rules out hypothyroid-driven absorption defect |
For women whose ferritin is low-normal (20–40 ng/mL) with normal CRP, a transferrin saturation below 20% is the strongest corroborating evidence for functional iron insufficiency warranting intervention. Similarly, symptoms of thiamine deficiency and low ferritin can overlap significantly in women with gut malabsorption — ordering both panels simultaneously saves time.
---
Evidence-Based Repletion Protocol
The therapeutic approach depends on the severity of depletion, the root cause, and the woman's tolerability of oral iron forms.
Oral Iron
Ferrous bisglycinate (iron glycinate) is the preferred oral form for tolerability and absorption. Studies comparing ferrous bisglycinate to ferrous sulfate find equivalent or superior increases in hemoglobin and ferritin at lower elemental doses — with significantly fewer gastrointestinal side effects (Milman et al., Acta Obstetricia et Gynecologica Scandinavica 2014; PMID: 24118858). A typical repletion dose is 25–50 mg elemental iron every other day.
Alternate-day dosing matters more than most practitioners realize. A 2017 study by Moretti et al. showed that hepcidin levels spike for 24 hours after an oral iron dose, suppressing absorption of the next dose if taken consecutively. Alternate-day dosing exploits the hepcidin trough and achieves comparable — sometimes superior — ferritin repletion with half the total iron load (Moretti et al., Blood 2015; PMID: 26289639).
Vitamin C co-administration reduces non-heme iron to its ferrous (absorbable) form. Taking 200–500 mg of ascorbic acid with each iron dose can increase absorption by 2–3 fold in women with borderline intake.
Dietary Strategy
- Pair plant iron sources with vitamin C at every meal (e.g., lentils with bell pepper, spinach with lemon)
- Avoid coffee, tea, and calcium-rich foods within 1 hour of iron-rich meals or supplemental iron
- Increase heme iron intake from red meat 2–3 times per week if not contraindicated
- Cook in cast iron cookware — measurable iron transfer occurs, particularly with acidic foods
Addressing the Root Cause
Repletion without addressing the cause is a temporary fix. Heavy menstrual bleeding may require gynecological evaluation; malabsorption requires GI workup; chronic stress-driven hepcidin elevation benefits from cortisol-normalizing strategies. Women with symptoms related to low libido driven by stress or hormonal imbalance often simultaneously present with low ferritin, reflecting the intersecting demands that chronic stress places on micronutrient stores.
---
What This Means for Your Formula
Ones formulates custom supplement plans based on lab results, wearable data, and symptom history — which means iron status is evaluated in context, not in isolation. Because ferritin requires a full panel to interpret correctly, Ones is designed to integrate CRP, transferrin saturation, and thyroid markers alongside ferritin before suggesting any iron-adjacent ingredient.
For women whose low ferritin is being driven or compounded by poor gut absorption, Ones includes Vitamin D3 + K2 (MK-7) at clinically meaningful doses. Vitamin D upregulates duodenal calcium-sensing receptor activity and has demonstrated modest positive effects on iron absorption efficiency in women with low baseline D levels — the two deficiencies are mechanistically linked, not coincidental (as explored in detail at low vitamin D symptoms and causes).
For women showing signs of stress-driven hepcidin elevation alongside low ferritin, Ones may include Ashwagandha KSM-66 at 600 mg — the clinically studied extract that has demonstrated statistically significant reductions in serum cortisol (by 27.9% in an 8-week RCT; Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Lowering cortisol-mediated IL-6 output is a legitimate upstream strategy for reducing hepcidin tone and improving iron utilization.
Where selenium status is also suboptimal — a common finding in women with gut malabsorption — Ones adds selenomethionine at 200 mcg, which supports glutathione peroxidase activity and reduces the oxidative burden that drives inflammatory hepcidin. The interplay between selenium deficiency and iron metabolism is an emerging area of clinical nutrition research that most single-ingredient supplement protocols miss entirely.
Ones does not include elemental iron in its capsule formulas (iron requires individualized prescription-level dosing and monitoring for toxicity risk), so women who need active repletion are referred to coordinate with their physician. What Ones addresses are the absorptive, inflammatory, and stress-related drivers that either caused the deficiency or will prevent repletion from working.
---
Key Takeaways
- Ferritin falls before hemoglobin does — a "normal" CBC does not rule out iron deficiency, and the functional optimal range for most women is 70–150 ng/mL, not the 10–20 ng/mL labs flag as the lower limit.
- The six root causes — menstrual blood loss, inadequate intake, malabsorption, elevated demand, inflammation-driven hepcidin elevation, and thyroid dysfunction — frequently overlap, and treating only one while ignoring the others leads to repletion failure.
- Inflammation falsely normalizes ferritin — always run CRP alongside ferritin; a ferritin of 50 ng/mL with a CRP of 10 mg/L may represent true stores of 20 ng/mL.
- Alternate-day ferrous bisglycinate with vitamin C is the evidence-based oral repletion strategy — every-day dosing triggers a hepcidin spike that blunts next-day absorption.
- Root-cause correction is non-negotiable — heavy periods, celiac disease, H. pylori, or chronic stress-driven hepcidin elevation must be addressed or ferritin will decline again once supplementation stops.
- Personalized context matters — women managing multiple simultaneous deficiencies benefit most from a lab-informed supplement strategy that accounts for the interactions between iron, vitamin D, selenium, and cortisol status.